THX Pharma Valuation Multiples

THX Pharma Overview

About THX Pharma

THX Pharma Formerly Theranexus SA is a France based biopharmaceutical company. It is engaged in developing drug candidates to be used in the treatment of central nervous system (CNS) disorders. The company’s therapeutics platform is based on simultaneously targeting neurons and glial cells by creating and developing innovative combinations of two distinct drugs: a CNS drug targeting neuronal activity; and a drug targeting glial cells. The drug candidates of the organization are THN102 to treat excessive daytime sleepiness in Parkinson’s disease, THN201 for the treatment of neurocognitive disorders in Alzheimer’s disease and THN101 for neuropathic pain.

Founded

2013

HQ

Employees

15

Website

theranexus.com

Sectors

BiopharmaceuticalsBioTech

Financials (FY)

Revenue: —

EBITDA: ($3M)

EV

$53M

Valuation Multiples

Multiples.vc

Start free trial

THX Pharma Financials

THX Pharma reported last fiscal year revenue of — and negative EBITDA of ($3M).

In the same fiscal year, THX Pharma generated ($3M) in gross profit, ($3M) in EBITDA losses, and had net loss of ($2M).

THX Pharma P&L

In the most recent fiscal year, THX Pharma reported revenue of — and EBITDA of ($3M).

THX Pharma expects next 12-month revenue of XXX and NTM EBITDA of XXX

THX Pharma Stock Performance

THX Pharma has current market cap of $52M, and enterprise value of $53M.

THX Pharma's stock price is $3.61.

THX Pharma Valuation Multiples

THX Pharma trades at (18.5x) EV/EBITDA.

THX Pharma Financial Valuation Multiples

As of April 11, 2026, THX Pharma has market cap of $52M and EV of $53M.

Equity research analysts estimate THX Pharma's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

THX Pharma has a P/E ratio of 13.4x.

THX Pharma Margins & Growth Rates

THX Pharma's revenue in the last fiscal year grew by —.

THX Pharma's revenue per employee in the last FY averaged $0.0M, while opex per employee averaged $-0.0M for the same period.

THX Pharma Public Comps

See public comps and valuation multiples for other Biopharmaceuticals comps.

THX Pharma M&A Activity

THX Pharma acquired XXX companies to date.

Last acquisition by THX Pharma was on XXXXXXXX, XXXXX. THX Pharma acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

THX Pharma Investment Activity

THX Pharma invested in XXX companies to date.

THX Pharma made its latest investment on XXXXXXXX, XXXXX. THX Pharma invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).